Literature DB >> 4976109

The host response to Calmette-Guérin bacillus infection in mice.

R V Blanden, M J Lefford, G B Mackaness.   

Abstract

Heterologous organisms (L. monocytogenes and S. typhimurium) were used to study the rate of development, magnitude, and persistence of the antimicrobial resistance engendered in mice by vaccination with BCG. These same methods were used to investigate the influence of prior vaccination on the host response to reinfection. The rate of onset and magnitude of the resistance produced by BCG varied with the vaccinating dose. Increased resistance was detected within 48 hr of injecting large numbers of BCG (approximately 10(8) viable units), but concurrent treatment with isoniazid interrupted its further development. An equal number of heat-killed organisms failed to influence host resistance significantly. The development of tuberculin sensitivity was also dependent upon the continued survival of the immunizing population of BCG. When vaccinated mice were reinfected with BCG, host resistance in spleen and liver was rapidly augmented to the accompaniment of striking changes in the morphology and microbicidal activity of the peritoneal macrophages. These changes occurred most rapidly in mice with a high level of delayed hypersensitivity at the time of reinfection.

Entities:  

Mesh:

Year:  1969        PMID: 4976109      PMCID: PMC2138639          DOI: 10.1084/jem.129.5.1079

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Brevity of the inductive phase in the immune response of mice to capsular polysaccharide antigens.

Authors:  P J Baker; M Landy
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

2.  The local nature of immunity in tuberculosis, illustrated histochemically in dermal BCG lesions.

Authors:  A M Dannenberg; O T Meyer; J R Esterly; T Kambara
Journal:  J Immunol       Date:  1968-05       Impact factor: 5.422

Review 3.  Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

Authors:  A M Dannenberg
Journal:  Bacteriol Rev       Date:  1968-06

Review 4.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

5.  [Cellular resistance to bacterial infection. IV. Active immunization and resistance of the macrophages of NCS mice to the intracellular multiplication of Listeria monocytogenes, Corynebacterium kutscheri and Brucella melitensis].

Authors:  R M Fauve; D Bouanchaud; A Delaunay
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-03

6.  Antibody formation. III. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs.

Authors:  J W UHR; M S FINKELSTEIN; J B BAUMANN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

7.  Antituberculous immunity induced in mice by vaccination with living cultures of attenuated tubercle bacilli.

Authors:  R J DUBOS; C H PIERCE; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

8.  THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. II. THE INFLUENCE OF SERUM ON GRANULE FORMATION, HYDROLASE PRODUCTION, AND PINOCYTOSIS.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

9.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  123 in total

1.  Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

Authors:  R Janssen; A Kruisselbrink; L Hoogteijling; J R Lamb; D B Young; J E Thole
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms.

Authors:  C A Brown; I N Brown
Journal:  Br J Exp Pathol       Date:  1982-04

3.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

4.  Antimycobacterial effect of lysates prepared from immunologically activated macrophages.

Authors:  I Kochan; C A Golden
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

5.  Nonspecific resistance to Listeria monocytogenes in mice infected and elicited with Staphylococcus aureus.

Authors:  R E Baughn
Journal:  Med Microbiol Immunol       Date:  1975-09-19       Impact factor: 3.402

6.  Interferon production by macrophages from adult and newborn rabbits bearing fibroma virus-induced tumors.

Authors:  P N Pathak; W A Tompkins
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

7.  Cell-mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes.

Authors:  R M Zinkernagel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

8.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Virulence of six strains of Mycobacterium bovis (BCG) in mice.

Authors:  N A Sher; S D Chaparas; J Pearson; M Chirigos
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

10.  Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.

Authors:  S C Agarwal; T Sundararaj
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.